CFDA: Yet another story? [RSABE / ABEL]

posted by libaiyi – China, 2018-06-12 11:09 (897 d 08:11 ago) – Posting: # 18887
Views: 4,174

Hi Helmut,

thanks for your help.

CFDA has relased the draft guidance for HVBE, which follows FDA method (RSABE).

I still have a question about EMA method. Do you mean if we follow EMA's guidance, the ABEL should be used rather than RSABE, please give me more advise.

thanks in advance. :-D:-D:-D

Complete thread:

Activity
 Admin contact
21,210 posts in 4,426 threads, 1,481 registered users;
online 4 (0 registered, 4 guests [including 4 identified bots]).
Forum time: Wednesday 18:21 CET (Europe/Vienna)

You can’t fix by analysis
what you bungled by design.    Richard J. Light, Judith D. Singer, John B. Willett

The Bioequivalence and Bioavailability Forum is hosted by
BEBAC Ing. Helmut Schütz
HTML5